|
1
|
Suh DH, Kim M, Kim HJ, Lee KH and Kim JW:
Major clinical research advances in gynecologic cancer in 2015. J
Gynecol Oncol. 27:e532016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clancy AA, Spaans JN and Weberpals JI: The
forgotten woman's cancer: Vulvar squamous cell carcinoma (VSCC) and
a targeted approach to therapy. Ann Oncol. 27:1696–1705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yap ML, Allo G, Cuartero J, Pintilie M,
Kamel-Reid S, Murphy J, Mackay H, Clarke B, Fyles A and Milosevic
M: Prognostic significance of human papilloma virus and p16
expression in patients with vulvar squamous cell carcinoma who
received radiotherapy. Clin Oncol (R Coll Radiol). 30:254–261.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones RW, Rowan DM and Stewart AW: Vulvar
intraepithelial neoplasia: Aspects of the natural history and
outcome in 405 women. Obstet Gynecol. 106:1319–1326. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hantschmann P, Sterzer S, Jeschke U and
Friese K: P53 expression in vulvar carcinoma, vulvar
intraepithelial neoplasia, squamous cell hyperplasia and lichen
sclerosus. Anticancer Res. 25:1739–1745. 2005.PubMed/NCBI
|
|
6
|
Jancárková N, Freitag P and Zivný J:
Vulvar carcinoma-retrospective study of 47 cases (epidemiology,
etiology and long-term results. Ceska Gynekol. 67:78–82. 2002.(In
Czech). PubMed/NCBI
|
|
7
|
Zhao L and Zhang Y and Zhang Y: Long
noncoding RNA CASC2 regulates hepatocellular carcinoma cell
oncogenesis through miR-362-5p/Nf-κB axis. J Cell Physiol.
233:6661–6670. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang GH, Du L, Li N, Zhang Y, Xiang Y,
Tang JH, Xia S, Zhang EE and Lv SQ: Methylation-mediated
miR-155-FAM133A axis contributes to the attenuated invasion and
migration of IDH mutant gliomas. Cancer Lett. 432:93–102. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo Y, Cao X, Chen J, Gu J, Zhao J and Sun
J: MicroRNA-224 suppresses osteoblast differentiation by inhibiting
SMAD4. J Cell Physiol. 233:6929–6937. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lekka E and Hall J: Non-coding RNAs in
disease. FEBS Lett. 592:2884–2900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tao L, Zhang CY, Guo L, Li X, Han NN, Zhou
Q and Liu ZL: MicroRNA-497 accelerates apoptosis while inhibiting
proliferation, migration, and invasion through negative regulation
of the MAPK/ERK signaling pathway via RAF-1. J Cell Physiol.
233:6578–6588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao H, Zhao H, Zhang Y and Zhou Y:
MicroRNA199b promotes cell proliferation and invasion in Wilms'
tumour by directly targeting runt-related transcription factor 3.
Mol Med Rep. 18:1812–1819. 2018.PubMed/NCBI
|
|
13
|
Liang Y, Zhang P, Li S, Li H, Song S and
Lu B: MicroRNA-873 acts as a tumor suppressor in esophageal cancer
by inhibiting differentiated embryonic chondrocyte expressed gene
2. Biomed Pharmacother. 105:582–589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang XH and Guo F: miR3147 serves as an
oncomiR in vulvar squamous cell cancer via Smad4 suppression. Mol
Med Rep. 17:6397–6404. 2018.PubMed/NCBI
|
|
15
|
Agostini A, Brunetti M, Davidson B, Trope
CG, Heim S, Panagopoulos I and Micci F: Expressions of miR-30c and
let-7a are inversely correlated with HMGA2 expression in squamous
cell carcinoma of the vulva. Oncotarget. 7:85058–85062. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hetland TE, Holth A, Kærn J, Flørenes VA,
Tropé CG and Davidson B: HMGA2 protein expression in ovarian serous
carcinoma effusions, primary tumors, and solid metastases. Virchows
Arch. 460:505–513. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang X and Wu X: miRNA expression profile
of vulvar squamous cell carcinoma and identification of the
oncogenic role of miR-590-5p. Oncol Rep. 35:398–408. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sznurkowski JJ: Vulvar cancer: Initial
management and systematic review of literature on currently applied
treatment approaches. Eur J Cancer Care (Engl). 25:638–646. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Preti M, Scurry J, Marchitelli CE and
Micheletti L: Vulvar intraepithelial neoplasia. Best Pract Res Clin
Obstet Gynaecol. 28:1051–1062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paul P, Chakraborty A, Sarkar D, Langthasa
M, Rahman M, Bari M, Singha RS, Malakar AK and Chakraborty S:
Interplay between miRNAs and human diseases. J Cell Physiol.
233:2007–2018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang LL, Zhang LF, Guo XH, Zhang DZ, Yang
F and Fan YY: Downregulation of miR-335-5p by long noncoding RNA
ZEB1-AS1 in gastric cancer promotes tumor proliferation and
invasion. DNA Cell Biol. 37:46–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Zhou L, Shi M, Kuang Y and Fang
L: Downregulation of miRNA-15a and miRNA-16 promote tumor
proliferation in multiple myeloma by increasing CABIN1 expression.
Oncol Lett. 15:1287–1296. 2018.PubMed/NCBI
|
|
23
|
Hu L, Wu H, Wan X, Liu L, He Y, Zhu L, Liu
S, Yao H and Zhu Z: MicroRNA-585 suppresses tumor proliferation and
migration in gastric cancer by directly targeting MAPK1. Biochem
Biophys Res Commun. 499:52–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ultimo S, Martelli AM, Zauli G, Vitale M,
Calin GA and Neri LM: Roles and clinical implications of microRNAs
in acute lymphoblastic leukemia. J Cell Physiol. 233:5642–5654.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pulido R: PTEN inhibition in human disease
therapy. Molecules. 23:E2852018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukherjee A and Karmakar P: Attenuation of
PTEN perturbs genomic stability via activation of Akt and
down-regulation of Rad51 in human embryonic kidney cells. Mol
Carcinog. 52:611–618. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng D, Zhang L, Yang G, Zhao L, Peng F,
Tian Y, Xiao X, Chung RT and Gong G: Hepatitis C virus NS5A drives
a PTEN-PI3K/Akt feedback loop to support cell survival. Liver Int.
35:1682–1691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tian K, Di R and Wang L: MicroRNA-23a
enhances migration and invasion through PTEN in osteosarcoma.
Cancer Gene Ther. 22:351–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Howitt J, Low LH, Putz U, Doan A, Lackovic
J, Goh CP, Gunnersen J, Silke J and Tan SS: Ndfip1 represses cell
proliferation by controlling Pten localization and signaling
specificity. J Mol Cell Biol. 7:119–131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Worby CA and Dixon JE: PTEN. Annu Rev
Biochem. 83:641–669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bera A, Ghosh-Choudhury N, Dey N, Das F,
Kasinath BS, Abboud HE and Choudhury GG: NFκB-mediated cyclin D1
expression by microRNA-21 influences renal cancer cell
proliferation. Cell Signal. 25:2575–2586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu DT, Yao HR, Li YY, Song YY and Su MY:
MicroRNA-19b promotes the migration and invasion of ovarian cancer
cells by inhibiting the PTEN/AKT signaling pathway. Oncol Lett.
16:559–565. 2018.PubMed/NCBI
|
|
34
|
Chen Z, Zhang M, Qiao Y, Yang J and Yin Q:
MicroRNA-1297 contributes to the progression of human cervical
carcinoma through PTEN. Artif Cells Nanomed Biotechnol. 46 (Suppl
2):S1120–S1126. 2018. View Article : Google Scholar
|
|
35
|
John RR, Malathi N, Ravindran C and
Anandan S: Mini review: Multifaceted role played by cyclin D1 in
tumor behavior. Indian J Dent Res. 28:187–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kozar K and Sicinski P: Cell cycle
progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell
Cycle. 4:388–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hong Y, Huang X, An L, Ye H, Ma K, Zhang F
and Xu Q: Overexpression of COPS3 promotes clear cell renal cell
carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin
D1 and Caspase-3. Exp Cell Res. 365:163–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun W, Guo F and Liu M: Upregulated WDR5
promotes gastric cancer formation by induced cyclin D1 expression.
J Cell Biochem. 119:3304–3316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Worsley SD, Ponder BA and Davies BR:
Overexpression of cyclin D1 in epithelial ovarian cancers. Gynecol
Oncol. 64:189–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
